QL Block for Postoperative Pain in Hip Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a pain relief method called the quadratus lumborum (QL) block for individuals undergoing hip replacement surgery. Researchers aim to determine how effectively this method reduces post-surgery pain compared to a saltwater solution. The trial includes two groups: one receiving the QL block with a pain reliever and another receiving a saltwater injection for comparison. It suits adults planning hip replacement surgery who are not allergic to local anesthetics and do not use opioids regularly. As an Early Phase 1 trial, this research focuses on understanding the QL block's effects in people, offering participants the chance to be among the first to experience this innovative pain relief method.
Do I need to stop taking my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, if you are using opioids regularly, you may not be eligible to participate.
What prior data suggests that the quadratus lumborum block is safe for postoperative pain management in hip surgery?
Research has shown that the quadratus lumborum (QL) block, particularly with ropivacaine, is generally safe. Studies have found that QL blocks effectively relieve pain after hip surgery, with no major safety issues reported. One analysis demonstrated that QL blocks provided significantly better pain relief compared to not using a block or using a placebo.
Another study found that older patients who received QL blocks experienced better recovery after hip surgery. The QL block is considered a promising method for managing pain in these surgeries. Although this trial is still in the early stages, existing evidence suggests that QL blocks are well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about the quadratus lumborum (QL) block for postoperative pain in hip surgery because it offers a new approach to pain management that specifically targets the nerves in the lower back. Unlike standard treatments such as opioids or epidural anesthesia that can have widespread effects on the body, the QL block uses ropivacaine, which is injected directly near the quadratus lumborum muscle to provide targeted pain relief. This method has the potential to reduce the reliance on systemic pain medications, minimizing side effects and enhancing recovery. By directly addressing pain at its source, the QL block could lead to more effective and efficient pain control after hip surgery.
What evidence suggests that the QL block is effective for postoperative pain in hip surgery?
Studies have shown that a quadratus lumborum (QL) block with ropivacaine effectively reduces pain after hip surgery. In this trial, participants in the intervention group will receive the QL block with 0.25% ropivacaine. Specifically, patients who received this block used about 15.78 mg less opioid medication in the first 24 hours after surgery compared to those who did not receive it. Research also indicates that the QL block provides longer-lasting pain relief. In hip surgeries, patients who had a QL block reported less pain and needed fewer painkillers immediately after the operation. These findings suggest that the QL block could improve pain management for people undergoing hip replacements.12678
Who Is on the Research Team?
Pamela Chia, MD
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
This trial is for adults having elective primary total hip arthroplasty. It's not suitable for those under 18, with allergies to local anesthetics, peripheral neuropathy, long-term opioid use, or conditions that contraindicate spinal and regional anesthesia like coagulopathy or site infections.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a quadratus lumborum nerve block with either ropivacaine or saline during primary total hip arthroplasty
Postoperative Monitoring
Pain scores and opioid usage are assessed over the first 48 hours after surgery
Follow-up
Participants are monitored for patient satisfaction, time to ambulation, and other recovery metrics until discharge
What Are the Treatments Tested in This Trial?
Interventions
- Quadratus Lumborum Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor